Coexpression of gene polymorphisms involved in bilirubin production and metabolism

Pediatrics

Volumn 122, Issue 1, 2008, Pages

  Lin, Zhili ^a   Fontaine, Jamie ^a   Watchko, Jon F ^b,c  

^a PERKINELMER INC   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Genetics; Glucose 6 phosphate dehydrogenase; Hyperbilirubinemia; Organic anion transporter polypeptide 1B1; Phenobarbital responsive enhancer module; Uridine diphosphate glucuronosyl transferase 1A1

Indexed keywords

ADENINE; BILIRUBIN; DNA; PHENOBARBITAL; THYMIDINE; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; ORGANIC ANION TRANSPORTER; SLCO1B1 PROTEIN, HUMAN;

ARTICLE; BILIRUBIN METABOLISM; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; FEMALE; G6PD GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; NEWBORN JAUNDICE; OATP1B1 GENE; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX; UGT1A1 GENE; UNITED STATES; CHILD; GENETIC POLYMORPHISM; GENETICS; HYPERBILIRUBINEMIA;

CHILD; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA, HEREDITARY; MALE; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, GENETIC;

EID: 48249150785     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-3249     Document Type: Article

References (52)

1. Watchko JF. Indirect hyperbilirubinemia in the neonate. In: Maisels MJ, Watchko JF, eds. Neonatal Jaundice. Amsterdam, Netherlands: Harwood Academic Publishers; 2000:51-66
2. Maisels MJ, Kring E. Length of stay, jaundice and hospital readmission. Pediatrics. 1998;101(6):995-998
3. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems- based approaches. J Perinatal. 2004;24(10):650-662
4. Perlstein MA. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am. 1960;7(3):665-687
5. Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinaemia in the era of genomics. Semin Neonatol. 2002;7(2):143-152
6. Watchko JF. Vigintiphobia revisited. Pediatrics. 2005;115(6): 1747-1753
7. Kaplan M, Hammerman C. Bilirubin and the genome: the hereditary basis of unconjugated neonatal hyperbilirubinemia. Curr Pharmacogenomics. 2005;3(1):21-42
8. Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol. 2003;38(1):107-117
9. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000;16(4):297-306
10. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A. 1997;94(22):12128-12132
11. Beutler E. G6PD deficiency. Blood. 1994;84(11):3613-3636
12. Huang CS, Huang MJ, Lin MS, Yang SS, Teng HC, Tang KS. Genetic factors related to unconjugated hyperbilirubinemia amongst adults. Pharmacogenet Genomics. 2005;15(1):43-50
13. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004;56(5):682-689
14. Kaplan M, Hammerman C. Severe neonatal hyperbilirubinemia: a potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol. 1998;25(3):575-590
15. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol. 2004;28(5):356-364
16. Watchko JF. Genetics and the risk of neonatal hyperbilirubinemia. Pediatr Res. 2004;56(5):677-678
17. Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose- 6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia. Gastroenterology. 2002;123(1):127-133
18. Bosma PJ, Roy Chowdhury J, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333(18): 1171-1175
19. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276(13):9626-9630
20. Briz O, Serrano MA, Maclas RI, Gonzalez-Gallego J, Marin JJ. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem J. 2003; 371(Pt 3):897-905
21. Beutler E, Gelbart T, Demina A. Racial variability in the UDP- glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA. 1998;95(14):8170-8174
22. Ferraris A, D'Amato G, Nobili V, et al. Combined test for UGT1A1-3279T->G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients. Genet Test. 2006;10(2):121-125
23. Kamisako T. What is Gilbert's syndrome? Lesson from genetic polymorphisms of UGT1A1 in Gilbert's syndrome from Asia. J Gastroenterol Hepatol. 2004;19(9):955-957
24. Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada M. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene. Pediatrics. 2000;106(5). Available at: www.pediatrics.org/cgi/content/full/106/5/e59
25. Maruo Y, D'Addario C, Mori A, et al. Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome. Hum Genet. 2004;115(6):525-526
26. Sugatani J, Yamakawa K, Yoshinari K, et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun. 2002;292(2):492-497
27. Takeuchi K, Kobayashi Y, Tamaki S, et al. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects. J Gastroenterol Hepatol. 2004;19(9):1023-1028
28. Yamamoto A, Nishio H, Waku S, et al. Gly71Arg mutation of the bilirubin UDP-glucuronosyltransferase 1A1 gene is associated with neonatal hyperbilirubinemia in the Japanese population. Kobe J Med Sci. 2002;48(3-4):73-77
29. Marzolini C, Tirona RG, Kim RB. Pharmacogenomics of the OATP and OAT families. Pharmacogenomics. 2004;5(3):273-282
30. Michalski C, Cui Y, Nies AT, et al. A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002;277(45):43058-43063
31. Nozawa T, Nakajima M, Tamai I, et al. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther. 2002; 302(2):804-813
32. Tirona RG, Leake BF, Merino G, Kim RB. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African- Americans. J Biol Chem. 2001;276(38):35669-35675
33. Ho RH, Choi L, Lee W, et al. Effect of drug transporter genotypes on pravastatin disposition in European- and African- American participants. Pharmacogenet Genomics. 2007;17(8): 647-656
34. Ho RH, Tirona RG, Leake BF, et al. Drug and bile acid transporters in rosuvastin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006;130(6):1793-1806
35. Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 1998;8(12):1229-1231
36. Lin Z, Fontaine JM, Freer DE, Naylor EW. Alternative DNA- based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab. 2005;86(1-2):212-219
37. Bennett CD, Campbell MN, Cook CJ et al. The LightTyper: high-throughput genotyping using fluorescent melting curve analysis. Biotechniques. 2003;34(6):1288-1292, 1294-1295
38. Lin Z, Suzow JG, Fontaine JM, Naylor EW. A high throughput beta-globin genotyping method by multiplexed melting temperature analysis. Mol Genet Metab. 2004;81(3):237-243
39. Murugesan G, Kottke-Marchant K, Ellis S, Agah R, Tubbs R. LightTyper platform for high-throughput clinical genotyping. Expert Rev Mol Diagn. 2005;5(3):457-471
40. Bancroft JD, Kreamer B, Gourley GR. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr. 1998; 132(4):656-660
41. Monaghan G, McLellan A, McGreehan A, et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbiliurbinemia in the newborn. J Pediatr. 1999;134(4):441-446
42. 8 allele in Caucasians. Blood Cells Mol Dis. 2007;38(2):78-82
43. 7TAA and -3279T>G mutations in UGT1A1 is not essential for pathogenesis of Gilbert syndrome. Liver Int. 2006;26(10):1302-1303
44. Costa E, Viera E, Dos Santos R. The polymorphism c.-3279T>G in the phenobarbital-responsive enhancer module of the bilirubin UDP- glucuronosyltransferase gene is associated with Gilbert's syndrome. Clin Chem. 2005;51(11):2204-2206
45. Ueyama H, Koiwai O, Soeda Y, et al. Analysis of the promoter of human bilirubin UDP-glucuronosyltransferase gene (UGT*1) in relevance to Gilbert's syndrome. Hepatol Res. 1997;9(2-3):152-163
46. Kaplan M, Hammerman C, Vreman HJ, Stevenson DK, Beutler E. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. J Pediatr. 2001;139(1):137-140
47. Ieiri I, Suzuki H, Kimura M, et al. Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. Hepatol Res. 2004;30(2):91-95
48. Wang P, Kim RB, Chowdhury JR, Wolkoff AW. The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport. J Biol Chem. 2003;278(23):20695-20699
49. Newman TB, Escobar GJ, Gonzales V, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization [published correction appears in Pediatrics. 2001;1(2):126]. Pediatrics. 1999;104(5 pt 2):1198-1203
50. Mathew C. Postgenomic technologies: hunting the genes for common disorders. BMJ. 2001;322(7293):1031-1034
51. Badano JL, Katsanis N. Beyond Mendel: an evolving view of humangenetic disease transmission. Nat Rev Genet. 2002;3(10):779-789
52. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155(6):487-495